Dr. Sennewald Medizintechnik GmbH

Hyperthermia Presentations/Symposia

ESTRO 2010, Barcelona

Udo Gaipl, Universitätsklinikum Erlangen
Immunological and biological rationale for hyperthermia in cancer treatment

Martine Franckena, Erasmus Medical Center Rotterdam
Where is hyperthermia already standard in clinical practice?

Peter Wust, Charité Universitätsmedizin Berlin
Physical and technological potentials of deep RF hyperthermia

DEGRO 2010, Magdeburg

Stephan Bodis, Kantonsspital Aarau
Innovative Hyperthermie und innovative Bestrahlung?
Martin Stuschke, Universitätsklinikum Essen
Protonen: eine universelle strahlentherapeutische Methode
Stephanie Combs, Universitätsklinikum Heidelberg
Schwere Teilchen im Fokus
Marco Schippers, Paul Scherrer Institut Villigen
Neue „preiswerte“ Beschleuniger?

SFRO 2009, Paris

Oliver J. Ott, Universitätsklinikum Erlangen
Evolution of clinical hyperthermia in radio-oncology
Hyperthermia and radiotherapy

Jacoba van der Zee, Erasmus Medical Center Rotterdam
Clinical evidence of benefit by hyperthermia

Gerard C. van Rhoon, Erasmus Medical Center Rotterdam
Principles of quality assurance in regional deep hyperthermia

Gerard Devant, Salt Lake City USA
Évolution technologique de l’hyperthermie guidée par l’imagerie

DEGRO 2009, Bremen

Oliver J. Ott, Universitätsklinikum Erlangen
Hyperthermia and radiation oncology: Clinical evolution

Gerard C. van Rhoon, Erasmus Medical Center Rotterdam
Principles of quality assurance in regional deep hyperthermia

Rainer Rienmüller, LKH – Universitätsklinikum Graz
MR-bound hybrid hyperthermia from a radiological point of view

Markus Thalheimer, Universitätsklinikum Heidelberg
Options for establishing hyperthermia in the German DRG system

Frederik Wenz, Universitätsklinikum Mannheim
Why hyperthermia?

Anneke Westermann, Academic Medical Center Amsterdam
Randomized phase III-study of chemotherapy versus chemotherapy plus hyperthermia for locally advanced cervical cancer

ESTRO 2008, Göteborg

Michael R. Horsman, University Hospital Aarhus
Hyperthermia: a powerful enhancer of radiotherapy

Peter Wust, Charité Berlin
MR controlled online optimization of patient heat patterns

Oliver J. Ott, Universitätsklinikum Erlangen
Targeted hyperthermia: a powerful trigger in oncology
Evidence based clinical hyperthermia in radiation oncology

Rolf D. Issels, Klinikum Großhadern der Universität München
Hyperthermia adds to chemotherapy

Stefan Bodis, Kantonspital Aarau
Case presentation

DEGRO 2008, Wien

Ellen L. Jones, Duke University Medical Center Durham
Recent developments and results in clinical hyperthermia in the United States

Martine Franckena, Erasmus Medical Center Rotterdam
Long-term outcome after radiotherapy with or without hyperthermia for locally advanced cervical cancer: an 12 year update of a randomized trial

Johanna Gellermann, Charité Universitätsmedizin Berlin
Technical innovations in hyperthermia – intensity modulation?

Oliver J. Ott, Universitätsklinikum Erlangen
Hyperthermia as an integral component of multimodal treatment concepts: current development in Europe

Udo Gaipl, Universitätsklinikum Erlangen
Death and immunogenicity of tumor cells after irradiation and/or hyperthermia

Frederik Wenz, Universitätsklinikum Mannheim
Why are we investing in hyperthermia?

ESTRO 2006, Leipzig

Peter Vaupel, Universität Mainz
The biologic rationale for thermal therapy

Peter Wust, Charité Berlin
The rationale, potential and state of the art of deep focused hyperthermia with and without MR monitoring

Ellen L. Jones, Duke University Medical Center Durham
Hyperthermia in breast and ovarian cancer: recent progress and new directions

Jacoba van der Zee, Erasmus Medical Center Rotterdam
Hyperthermia in cervix and vagina cancer

Oliver J. Ott, Universitätsklinikum Erlangen
Targeted hyperthermia
Bladder, prostate and rectal cancer: samples for an adjuvant role of deep focused hyperthermia

Rüdiger Wessalowski, Universitätsklinikum Düsseldorf
Refractory high malignant soft tissue sarcoma in children and adolescents